{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:07:06Z","timestamp":1792678026414,"version":"4.5.0"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T00:00:00Z","timestamp":1388448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/nrd4176","type":"journal-article","created":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T03:12:26Z","timestamp":1388459546000},"page":"21-38","source":"Crossref","is-referenced-by-count":539,"title":["Therapeutic opportunities of the IL-22\u2013IL-22R1 system"],"prefix":"10.1038","volume":"13","author":[{"given":"Robert","family":"Sabat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,31]]},"reference":[{"key":"BFnrd4176_CR1","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.4049\/jimmunol.164.4.1814","volume":"164","author":"L Dumoutier","year":"2000","unstructured":"Dumoutier, L., Louahed, J. & Renauld, J. C. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. 164, 1814\u20131819 (2000). This article describes the discovery of IL-22.","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR2","doi-asserted-by":"publisher","first-page":"10144","DOI":"10.1073\/pnas.170291697","volume":"97","author":"L Dumoutier","year":"2000","unstructured":"Dumoutier, L., Van Roost, E., Colau, D. & Renauld, J. C. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl Acad. Sci. USA 97, 10144\u201310149 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd4176_CR3","doi-asserted-by":"publisher","first-page":"31335","DOI":"10.1074\/jbc.M005304200","volume":"275","author":"MH Xie","year":"2000","unstructured":"Xie, M. H. et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 275, 31335\u201331339 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrd4176_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","volume":"29","author":"W Ouyang","year":"2011","unstructured":"Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A. & Hymowitz, S. G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29, 71\u2013109 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrd4176_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cytogfr.2010.11.001","volume":"21","author":"R Sabat","year":"2010","unstructured":"Sabat, R. IL-10 family of cytokines. Cytokine Growth Factor Rev. 21, 315\u2013324 (2010).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrd4176_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","volume":"21","author":"K Wolk","year":"2004","unstructured":"Wolk, K. et al. IL-22 increases the innate immunity of tissues. Immunity 21, 241\u2013254 (2004). This paper shows, for the first time, that IL-22 does not regulate the function of immune cells, identifies keratinocytes as the target cells of IL-22 (in which IL-22 induces antibacterial protein production) and associates IL-22 with chronic inflammatory skin diseases.","journal-title":"Immunity"},{"key":"BFnrd4176_CR7","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S0969-2126(02)00797-9","volume":"10","author":"RA Nagem","year":"2002","unstructured":"Nagem, R. A. et al. Crystal structure of recombinant human interleukin-22. Structure 10, 1051\u20131062 (2002).","journal-title":"Structure"},{"key":"BFnrd4176_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1107\/S0907444905009601","volume":"61","author":"T Xu","year":"2005","unstructured":"Xu, T., Logsdon, N. J. & Walter, M. R. Structure of insect-cell-derived IL-22. Acta Crystallogr. D Biol. Crystallogr. 61, 942\u2013950 (2005).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnrd4176_CR9","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1529\/biophysj.107.112664","volume":"94","author":"M de Oliveira Neto","year":"2008","unstructured":"de Oliveira Neto, M. et al. Interleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains. Biophys. J. 94, 1754\u20131765 (2008).","journal-title":"Biophys. J."},{"key":"BFnrd4176_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1089\/10799900260442520","volume":"22","author":"NJ Logsdon","year":"2002","unstructured":"Logsdon, N. J., Jones, B. C., Josephson, K., Cook, J. & Walter, M. R. Comparison of interleukin-22 and interleukin-10 soluble receptor complexes. J. Interferon Cytokine Res. 22, 1099\u20131112 (2002).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFnrd4176_CR11","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.4049\/jimmunol.168.11.5397","volume":"168","author":"K Wolk","year":"2002","unstructured":"Wolk, K., Kunz, S., Asadullah, K. & Sabat, R. Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 168, 5397\u20135402 (2002).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR12","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","volume":"203","author":"SC Liang","year":"2006","unstructured":"Liang, S. C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271\u20132279 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR13","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/sj.cr.7310106","volume":"16","author":"Y Chung","year":"2006","unstructured":"Chung, Y. et al. Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes. Cell Res. 16, 902\u2013907 (2006).","journal-title":"Cell Res."},{"key":"BFnrd4176_CR14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648\u2013651 (2007).","journal-title":"Nature"},{"key":"BFnrd4176_CR15","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ni.2134","volume":"12","author":"S Rutz","year":"2011","unstructured":"Rutz, S. et al. Transcription factor c-Maf mediates the TGF-\u03b2-dependent suppression of IL-22 production in TH17 cells. Nature Immunol. 12, 1238\u20131245 (2011).","journal-title":"Nature Immunol."},{"key":"BFnrd4176_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1767","volume":"10","author":"T Duhen","year":"2009","unstructured":"Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. & Sallusto, F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nature Immunol. 10, 857\u2013863 (2009).","journal-title":"Nature Immunol."},{"key":"BFnrd4176_CR17","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ni.1770","volume":"10","author":"S Trifari","year":"2009","unstructured":"Trifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K. & Spits, H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells. Nature Immunol. 10, 864\u2013871 (2009).","journal-title":"Nature Immunol."},{"key":"BFnrd4176_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cytogfr.2010.08.002","volume":"21","author":"E Witte","year":"2010","unstructured":"Witte, E., Witte, K., Warszawska, K., Sabat, R. & Wolk, K. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev. 21, 365\u2013379 (2010).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrd4176_CR19","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.immuni.2008.11.001","volume":"29","author":"N Satoh-Takayama","year":"2008","unstructured":"Satoh-Takayama, N. et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958\u2013970 (2008).","journal-title":"Immunity"},{"key":"BFnrd4176_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.immuni.2010.12.009","volume":"34","author":"GF Sonnenberg","year":"2011","unstructured":"Sonnenberg, G. F., Monticelli, L. A., Elloso, M. M., Fouser, L. A. & Artis, D. CD4+ lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34, 122\u2013134 (2011).","journal-title":"Immunity"},{"key":"BFnrd4176_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1084\/jem.20092029","volume":"207","author":"N Satoh-Takayama","year":"2010","unstructured":"Satoh-Takayama, N. et al. IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J. Exp. Med. 207, 273\u2013280 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ni.1668","volume":"10","author":"T Cupedo","year":"2009","unstructured":"Cupedo, T. et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nature Immunol. 10, 66\u201374 (2009).","journal-title":"Nature Immunol."},{"key":"BFnrd4176_CR23","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1084\/jem.20122097","volume":"209","author":"G Sciume","year":"2012","unstructured":"Sciume, G. et al. Distinct requirements for T-bet in gut innate lymphoid cells. J. Exp. Med. 209, 2331\u20132338 (2012).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ni.2187","volume":"13","author":"JS Lee","year":"2012","unstructured":"Lee, J. S. et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nature Immunol. 13, 144\u2013151 (2012).","journal-title":"Nature Immunol."},{"key":"BFnrd4176_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2011.11.011","volume":"36","author":"J Qiu","year":"2012","unstructured":"Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92\u2013104 (2012).","journal-title":"Immunity"},{"key":"BFnrd4176_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/ni.2545","volume":"14","author":"LC Rankin","year":"2013","unstructured":"Rankin, L. C. et al. The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway. Nature Immunol. 14, 389\u2013395 (2013).","journal-title":"Nature Immunol."},{"key":"BFnrd4176_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits, H. et al. Innate lymphoid cells \u2014 a proposal for uniform nomenclature. Nature Rev. Immunol. 13, 145\u2013149 (2013).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrd4176_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm1720","volume":"14","author":"Y Zheng","year":"2008","unstructured":"Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Med. 14, 282\u2013289 (2008). This is the first paper that demonstrates the essential role of IL-22 in the protection against bacterial colitis in mice.","journal-title":"Nature Med."},{"key":"BFnrd4176_CR29","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.immuni.2012.08.024","volume":"37","author":"R Basu","year":"2012","unstructured":"Basu, R. et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 37, 1061\u20131075 (2012).","journal-title":"Immunity"},{"key":"BFnrd4176_CR30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1189\/jlb.0807525","volume":"83","author":"K Wolk","year":"2008","unstructured":"Wolk, K. et al. Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J. Leukoc. Biol. 83, 1181\u20131193 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrd4176_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1053\/j.gastro.2011.04.007","volume":"141","author":"I Monteleone","year":"2011","unstructured":"Monteleone, I. et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 141, 237\u2013248 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrd4176_CR32","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1074\/jbc.M007837200","volume":"276","author":"SV Kotenko","year":"2001","unstructured":"Kotenko, S. V. et al. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10R\u03b2) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J. Biol. Chem. 276, 2725\u20132732 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrd4176_CR33","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.str.2008.06.005","volume":"16","author":"BC Jones","year":"2008","unstructured":"Jones, B. C., Logsdon, N. J. & Walter, M. R. Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure 16, 1333\u20131344 (2008).","journal-title":"Structure"},{"key":"BFnrd4176_CR34","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1016\/j.febslet.2008.07.046","volume":"582","author":"L Bleicher","year":"2008","unstructured":"Bleicher, L. et al. Crystal structure of the IL-22\/IL-22R1 complex and its implications for the IL-22 signaling mechanism. FEBS Lett. 582, 2985\u20132992 (2008).","journal-title":"FEBS Lett."},{"key":"BFnrd4176_CR35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.str.2010.02.009","volume":"18","author":"SI Yoon","year":"2010","unstructured":"Yoon, S. I. et al. Structure and mechanism of receptor sharing by the IL-10R2 common chain. Structure 18, 638\u2013648 (2010).","journal-title":"Structure"},{"key":"BFnrd4176_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jmb.2004.07.069","volume":"342","author":"NJ Logsdon","year":"2004","unstructured":"Logsdon, N. J. et al. The IL-10R2 binding hot spot on IL-22 is located on the N-terminal helix and is dependent on N-linked glycosylation. J. Mol. Biol. 342, 503\u2013514 (2004).","journal-title":"J. Mol. Biol."},{"key":"BFnrd4176_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.gene.6364144","volume":"6","author":"K Wolk","year":"2005","unstructured":"Wolk, K. et al. Is there an interaction between interleukin-10 and interleukin-22? Genes Immun. 6, 8\u201318 (2005).","journal-title":"Genes Immun."},{"key":"BFnrd4176_CR38","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.jmb.2008.07.046","volume":"382","author":"PW Wu","year":"2008","unstructured":"Wu, P. W. et al. IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22. J. Mol. Biol. 382, 1168\u20131183 (2008).","journal-title":"J. Mol. Biol."},{"key":"BFnrd4176_CR39","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.4049\/jimmunol.167.7.3545","volume":"167","author":"L Dumoutier","year":"2001","unstructured":"Dumoutier, L., Leemans, C., Lejeune, D., Kotenko, S. V. & Renauld, J. C. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol. 167, 3545\u20133549 (2001).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR40","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.1074\/jbc.M106043200","volume":"277","author":"M Wang","year":"2002","unstructured":"Wang, M., Tan, Z., Zhang, R., Kotenko, S. V. & Liang, P. Interleukin 24 (MDA-7\/MOB-5) signals through two heterodimeric receptors, IL-22R1\/IL-20R2 and IL-20R1\/IL-20R2. J. Biol. Chem. 277, 7341\u20137347 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrd4176_CR41","doi-asserted-by":"publisher","first-page":"33676","DOI":"10.1074\/jbc.M204204200","volume":"277","author":"D Lejeune","year":"2002","unstructured":"Lejeune, D. et al. Interleukin-22 (IL-22) activates the JAK\/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J. Biol. Chem. 277, 33676\u201333682 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrd4176_CR42","doi-asserted-by":"publisher","first-page":"26377","DOI":"10.1074\/jbc.M109.007955","volume":"284","author":"L Dumoutier","year":"2009","unstructured":"Dumoutier, L., de Meester, C., Tavernier, J. & Renauld, J. C. New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain. J. Biol. Chem. 284, 26377\u201326384 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrd4176_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1105166","volume":"307","author":"ZL Yuan","year":"2005","unstructured":"Yuan, Z. L., Guan, Y. J., Chatterjee, D. & Chin, Y. E. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 307, 269\u2013273 (2005).","journal-title":"Science"},{"key":"BFnrd4176_CR44","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ncb1857","volume":"11","author":"Y Nie","year":"2009","unstructured":"Nie, Y. et al. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nature Cell Biol. 11, 492\u2013500 (2009).","journal-title":"Nature Cell Biol."},{"key":"BFnrd4176_CR45","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1096\/fj.10-172288","volume":"25","author":"R Sestito","year":"2011","unstructured":"Sestito, R. et al. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J. 25, 916\u2013927 (2011).","journal-title":"FASEB J."},{"key":"BFnrd4176_CR46","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1053\/j.gastro.2005.06.071","volume":"129","author":"A Andoh","year":"2005","unstructured":"Andoh, A. et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129, 969\u2013984 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrd4176_CR47","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/art.20965","volume":"52","author":"H Ikeuchi","year":"2005","unstructured":"Ikeuchi, H. et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 52, 1037\u20131046 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrd4176_CR48","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/eji.200535503","volume":"36","author":"K Wolk","year":"2006","unstructured":"Wolk, K. et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36, 1309\u20131323 (2006).","journal-title":"Eur. J. Immunol."},{"key":"BFnrd4176_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11010-012-1389-5","volume":"369","author":"X Zhu","year":"2012","unstructured":"Zhu, X. et al. Participation of Gab1 and Gab2 in IL-22-mediated keratinocyte proliferation, migration, and differentiation. Mol. Cell Biochem. 369, 255\u2013266 (2012).","journal-title":"Mol. Cell Biochem."},{"key":"BFnrd4176_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cyto.2012.06.316","volume":"60","author":"A Mitra","year":"2012","unstructured":"Mitra, A., Raychaudhuri, S. K. & Raychaudhuri, S. P. IL-22 induced cell proliferation is regulated by PI3K\/Akt\/mTOR signaling cascade. Cytokine 60, 38\u201342 (2012).","journal-title":"Cytokine"},{"key":"BFnrd4176_CR51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1165\/rcmb.2003-0285OC","volume":"31","author":"HA Whittington","year":"2004","unstructured":"Whittington, H. A., Armstrong, L., Uppington, K. M. & Millar, A. B. Interleukin-22: a potential immunomodulatory molecule in the lung. Am. J. Respir. Cell. Mol. Biol. 31, 220\u2013226 (2004).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"BFnrd4176_CR52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nm1710","volume":"14","author":"SJ Aujla","year":"2008","unstructured":"Aujla, S. J. et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nature Med. 14, 275\u2013281 (2008). This paper describes, for the first time, the essential role of IL-22 in the defence against extracellular Gram-negative bacteria in murine lungs and shows the additive action of IL-17 and IL-22 with respect to chemokine induction.","journal-title":"Nature Med."},{"key":"BFnrd4176_CR53","first-page":"534","volume":"118","author":"K Sugimoto","year":"2008","unstructured":"Sugimoto, K. et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534\u2013544 (2008). This paper demonstrates, for the first time, the therapeutic potency for IL-22 in a mouse model of ulcerative colitis and describes a new effect of IL-22: the induction of mucus proteins.","journal-title":"J. Clin. Invest."},{"key":"BFnrd4176_CR54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","volume":"87","author":"K Wolk","year":"2009","unstructured":"Wolk, K. et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-\u03b3 are not. J. Mol. Med. 87, 523\u2013536 (2009). This paper describes the phenotype of transgenic IL-22-overexpressing mice and highlights the effects of IL-22 on keratinocytes in comparison with the effects of IL-17 and IFN\u03b3 with respect to psoriasis.","journal-title":"J. Mol. Med."},{"key":"BFnrd4176_CR55","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1089\/107999001317205178","volume":"21","author":"S Aggarwal","year":"2001","unstructured":"Aggarwal, S., Xie, M. H., Maruoka, M., Foster, J. & Gurney, A. L. Acinar cells of the pancreas are a target of interleukin-22. J. Interferon Cytokine Res. 21, 1047\u20131053 (2001).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFnrd4176_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/MPA.0b013e3181594258","volume":"36","author":"M Shioya","year":"2008","unstructured":"Shioya, M., Andoh, A., Kakinoki, S., Nishida, A. & Fujiyama, Y. Interleukin 22 receptor 1 expression in pancreas islets. Pancreas 36, 197\u2013199 (2008).","journal-title":"Pancreas"},{"key":"BFnrd4176_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.1218004","volume":"336","author":"JA Dudakov","year":"2012","unstructured":"Dudakov, J. A. et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science 336, 91\u201395 (2012). By demonstrating the IL-22-mediated increase in thymic epithelial cell proliferation and survival, this paper suggests regenerative strategies for improving immune competence after thymic insult.","journal-title":"Science"},{"key":"BFnrd4176_CR58","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","volume":"37","author":"AM Hanash","year":"2012","unstructured":"Hanash, A. M. et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 37, 339\u2013350 (2012). This paper identifies intestinal stem cells as IL-22 target cells and demonstrates that IL-22 deficiency in recipients increases their mortality and tissue damage during acute GvHD.","journal-title":"Immunity"},{"key":"BFnrd4176_CR59","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1053\/j.gastro.2012.03.044","volume":"143","author":"D Feng","year":"2012","unstructured":"Feng, D. et al. Interleukin-22 promotes proliferation of liver stem\/progenitor cells in mice and patients with chronic hepatitis B virus infection. Gastroenterology 143, 188\u2013198 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrd4176_CR60","doi-asserted-by":"publisher","first-page":"7090","DOI":"10.4049\/jimmunol.166.12.7090","volume":"166","author":"L Dumoutier","year":"2001","unstructured":"Dumoutier, L., Lejeune, D., Colau, D. & Renauld, J. C. Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor\/IL-22. J. Immunol. 166, 7090\u20137095 (2001).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR61","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.gene.6363786","volume":"2","author":"BH Gruenberg","year":"2001","unstructured":"Gruenberg, B. H. et al. A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta. Genes Immun. 2, 329\u2013334 (2001).","journal-title":"Genes Immun."},{"key":"BFnrd4176_CR62","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.4049\/jimmunol.166.12.7096","volume":"166","author":"SV Kotenko","year":"2001","unstructured":"Kotenko, S. V. et al. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J. Immunol. 166, 7096\u20137103 (2001).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR63","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.1073\/pnas.171303198","volume":"98","author":"W Xu","year":"2001","unstructured":"Xu, W. et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc. Natl Acad. Sci. USA 98, 9511\u20139516 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd4176_CR64","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/sj.gene.6363947","volume":"4","author":"CC Wei","year":"2003","unstructured":"Wei, C. C., Ho, T. W., Liang, W. G., Chen, G. Y. & Chang, M. S. Cloning and characterization of mouse IL-22 binding protein. Genes Immun. 4, 204\u2013211 (2003).","journal-title":"Genes Immun."},{"key":"BFnrd4176_CR65","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/sj.gene.6364104","volume":"5","author":"B Weiss","year":"2004","unstructured":"Weiss, B. et al. Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart. Genes Immun. 5, 330\u2013336 (2004).","journal-title":"Genes Immun."},{"key":"BFnrd4176_CR66","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.4049\/jimmunol.178.9.5973","volume":"178","author":"K Wolk","year":"2007","unstructured":"Wolk, K. et al. IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J. Immunol. 178, 5973\u20135981 (2007).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR67","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.febslet.2009.03.006","volume":"583","author":"PR de Moura","year":"2009","unstructured":"de Moura, P. R. et al. Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22. FEBS Lett. 583, 1072\u20131077 (2009).","journal-title":"FEBS Lett."},{"key":"BFnrd4176_CR68","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nature11535","volume":"491","author":"S Huber","year":"2012","unstructured":"Huber, S. et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491, 259\u2013263 (2012). This article demonstrates the significance of endogenous IL-22BP  in vivo  and the importance of IL-22 action during inflammation-amplified tumorigenesis in the colon.","journal-title":"Nature"},{"key":"BFnrd4176_CR69","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.4049\/jimmunol.177.6.3635","volume":"177","author":"H Chang","year":"2006","unstructured":"Chang, H. et al. Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. J. Immunol. 177, 3635\u20133643 (2006).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR70","doi-asserted-by":"publisher","unstructured":"Martin, J. C. et al. Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid. Mucosal Immunol. \n                    http:\/\/dx.doi.org\/10.1038\/mi.2013.28\n                    \n                   (2013).","DOI":"10.1038\/mi.2013.28"},{"key":"BFnrd4176_CR71","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.4049\/jimmunol.0903416","volume":"184","author":"MS Wilson","year":"2010","unstructured":"Wilson, M. S. et al. Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J. Immunol. 184, 4378\u20134390 (2010).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR72","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nri3228","volume":"12","author":"RL Gallo","year":"2012","unstructured":"Gallo, R. L. & Hooper, L. V. Epithelial antimicrobial defence of the skin and intestine. Nature Rev. Immunol. 12, 503\u2013516 (2012).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrd4176_CR73","doi-asserted-by":"publisher","first-page":"G827","DOI":"10.1152\/ajpgi.00513.2005","volume":"290","author":"S Brand","year":"2006","unstructured":"Brand, S. et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest Liver Physiol. 290, G827\u2013G838 (2006).","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"BFnrd4176_CR74","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/labinvest.2009.147","volume":"90","author":"A Sekikawa","year":"2010","unstructured":"Sekikawa, A. et al. Involvement of the IL-22\/REG I\u03b1 axis in ulcerative colitis. Lab Invest. 90, 496\u2013505 (2010).","journal-title":"Lab Invest."},{"key":"BFnrd4176_CR75","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1089\/jir.2010.0064","volume":"30","author":"K Wolk","year":"2010","unstructured":"Wolk, K., Witte, K. & Sabat, R. Interleukin-28 and interleukin-29: novel regulators of skin biology. J. Interferon Cytokine Res. 30, 617\u2013628 (2010).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFnrd4176_CR76","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","volume":"174","author":"K Boniface","year":"2005","unstructured":"Boniface, K. et al. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174, 3695\u20133702 (2005).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR77","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.4049\/jimmunol.178.4.2229","volume":"178","author":"SM Sa","year":"2007","unstructured":"Sa, S. M. et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J. Immunol. 178, 2229\u20132240 (2007).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR78","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/mi.2012.49","volume":"6","author":"P Kumar","year":"2013","unstructured":"Kumar, P., Thakar, M. S., Ouyang, W. & Malarkannan, S. IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol. 6, 69\u201382 (2013).","journal-title":"Mucosal Immunol."},{"key":"BFnrd4176_CR79","doi-asserted-by":"publisher","first-page":"e21799","DOI":"10.1371\/journal.pone.0021799","volume":"6","author":"C Taube","year":"2011","unstructured":"Taube, C. et al. IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS ONE 6, e21799 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrd4176_CR80","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1002\/eji.200939687","volume":"39","author":"K Wolk","year":"2009","unstructured":"Wolk, K. et al. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. Eur. J. Immunol. 39, 3570\u20133581 (2009).","journal-title":"Eur. J. Immunol."},{"key":"BFnrd4176_CR81","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1053\/j.gastro.2012.08.051","volume":"143","author":"J Xue","year":"2012","unstructured":"Xue, J., Nguyen, D. T. & Habtezion, A. Aryl hydrocarbon receptor regulates pancreatic IL-22 production and protects mice from acute pancreatitis. Gastroenterology 143, 1670\u20131680 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrd4176_CR82","doi-asserted-by":"publisher","first-page":"249","DOI":"10.7150\/ijbs.3967","volume":"8","author":"D Feng","year":"2012","unstructured":"Feng, D. et al. Interleukin-22 ameliorates cerulein-induced pancreatitis in mice by inhibiting the autophagic pathway. Int. J. Biol. Sci. 8, 249\u2013257 (2012). This is the first study to show that the increase in IL-22 reduces the severity of acute and chronic pancreatitis in mice.","journal-title":"Int. J. Biol. Sci."},{"key":"BFnrd4176_CR83","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2045-9769-2-2","volume":"2","author":"T Hill","year":"2013","unstructured":"Hill, T. et al. The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genes. Cell Regener. 2, 2 (2013).","journal-title":"Cell Regener."},{"key":"BFnrd4176_CR84","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1053\/j.gastro.2011.06.051","volume":"141","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology 141, 1897\u20131906 (2011).","journal-title":"Gastroenterology"},{"key":"BFnrd4176_CR85","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.4049\/jimmunol.0904091","volume":"185","author":"SC Liang","year":"2010","unstructured":"Liang, S. C. et al. IL-22 induces an acute-phase response. J. Immunol. 185, 5531\u20135538 (2010).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR86","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/hep.20184","volume":"39","author":"S Radaeva","year":"2004","unstructured":"Radaeva, S., Sun, R., Pan, H. N., Hong, F. & Gao, B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39, 1332\u20131342 (2004). This is the first out of many papers showing the protective role of IL-22 in different types of hepatitis.","journal-title":"Hepatology"},{"key":"BFnrd4176_CR87","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/hep.24339","volume":"54","author":"O Park","year":"2011","unstructured":"Park, O. et al. In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 54, 252\u2013261 (2011).","journal-title":"Hepatology"},{"key":"BFnrd4176_CR88","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.antiviral.2012.12.018","volume":"97","author":"B Wang","year":"2013","unstructured":"Wang, B. et al. IL-17A but not IL-22 suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line. Antiviral Res. 97, 285\u2013292 (2013).","journal-title":"Antiviral Res."},{"key":"BFnrd4176_CR89","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/hep.23837","volume":"52","author":"SH Ki","year":"2010","unstructured":"Ki, S. H. et al. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52, 1291\u20131300 (2010).","journal-title":"Hepatology"},{"key":"BFnrd4176_CR90","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/art.33446","volume":"64","author":"KW Kim","year":"2012","unstructured":"Kim, K. W. et al. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum. 64, 1015\u20131023 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrd4176_CR91","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.4049\/jimmunol.0900459","volume":"184","author":"S Lo Re","year":"2010","unstructured":"Lo Re, S. et al. IL-17A-producing \u03b3\u03b4 T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J. Immunol. 184, 6367\u20136377 (2010).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR92","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/jid.2012.463","volume":"133","author":"HM McGee","year":"2013","unstructured":"McGee, H. M. et al. IL-22 promotes fibroblast-mediated wound repair in the skin. J. Invest. Dermatol. 133, 1321\u20131329 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"BFnrd4176_CR93","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.clindermatol.2007.08.002","volume":"25","author":"R Sabat","year":"2007","unstructured":"Sabat, R., Sterry, W., Philipp, S. & Wolk, K. Three decades of psoriasis research: where has it led us? Clin. Dermatol. 25, 504\u2013509 (2007).","journal-title":"Clin. Dermatol."},{"key":"BFnrd4176_CR94","doi-asserted-by":"publisher","first-page":"204ra129","DOI":"10.1126\/scitranslmed.3006245","volume":"5","author":"K Wolk","year":"2013","unstructured":"Wolk, K. et al. IL-29 is produced by TH17 cells and mediates the cutaneous antiviral competence in psoriasis. Sci Transl Med. 5, 204ra129 (2013).","journal-title":"Sci Transl Med."},{"key":"BFnrd4176_CR95","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","volume":"123","author":"KE Nograles","year":"2009","unstructured":"Nograles, K. E. et al. IL-22-producing \u201cT22\u201d T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J. Allergy Clin. Immunol. 123, 1244\u20131252 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrd4176_CR96","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","volume":"186","author":"K Wolk","year":"2011","unstructured":"Wolk, K. et al. Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J. Immunol. 186, 1228\u20131239 (2011).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR97","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/j.1523-1747.2003.12626.x","volume":"121","author":"J Romer","year":"2003","unstructured":"Romer, J. et al. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine A or calcipotriol. J. Invest. Dermatol. 121, 1306\u20131311 (2003).","journal-title":"J. Invest. Dermatol."},{"key":"BFnrd4176_CR98","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.1600-0625.2006.00516.x","volume":"15","author":"S Kunz","year":"2006","unstructured":"Kunz, S. et al. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp. Dermatol. 15, 991\u20131004 (2006).","journal-title":"Exp. Dermatol."},{"key":"BFnrd4176_CR99","first-page":"597","volume":"118","author":"HL Ma","year":"2008","unstructured":"Ma, H. L. et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J. Clin. Invest. 118, 597\u2013607 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnrd4176_CR100","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4049\/jimmunol.1102224","volume":"188","author":"AB Van Belle","year":"2012","unstructured":"Van Belle, A. B. et al. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J. Immunol. 188, 462\u2013469 (2012).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR101","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ni.2479","volume":"14","author":"C Wang","year":"2013","unstructured":"Wang, C. et al. The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90. Nature Immunol. 14, 72\u201381 (2013).","journal-title":"Nature Immunol."},{"key":"BFnrd4176_CR102","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1084\/jem.20071094","volume":"204","author":"LC Zaba","year":"2007","unstructured":"Zaba, L. C. et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 204, 3183\u20133194 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR103","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0092-8674(01)00187-8","volume":"104","author":"H Blumberg","year":"2001","unstructured":"Blumberg, H. et al. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104, 9\u201319 (2001).","journal-title":"Cell"},{"key":"BFnrd4176_CR104","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.4049\/jimmunol.0901829","volume":"184","author":"M He","year":"2010","unstructured":"He, M. & Liang, P. IL-24 transgenic mice: in vivo evidence of overlapping functions for IL-20, IL-22, and IL-24 in the epidermis. J. Immunol. 184, 1793\u20131798 (2010).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR105","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2133.2008.08890.x","volume":"160","author":"K Stenderup","year":"2009","unstructured":"Stenderup, K. et al. Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model. Br. J. Dermatol. 160, 284\u2013296 (2009).","journal-title":"Br. J. Dermatol."},{"key":"BFnrd4176_CR106","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jaci.2013.07.029","volume":"132","author":"Y Teraki","year":"2013","unstructured":"Teraki, Y., Sakurai, A. & Izaki, S. IL-13\/IL-22-coproducing T cells, a novel subset, are increased in atopic dermatitis. J. Allergy Clin. Immunol. 132, 971\u2013974 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrd4176_CR107","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1056\/NEJMoa021481","volume":"347","author":"PY Ong","year":"2002","unstructured":"Ong, P. Y. et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347, 1151\u20131160 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrd4176_CR108","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GB Jemec","year":"2012","unstructured":"Jemec, G. B. Clinical practice. Hidradenitis suppurativa. N. Engl. J. Med. 366, 158\u2013164 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrd4176_CR109","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1084\/jem.20101712","volume":"208","author":"A Geremia","year":"2011","unstructured":"Geremia, A. et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J. Exp. Med. 208, 1127\u20131133 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR110","doi-asserted-by":"publisher","first-page":"687","DOI":"10.4049\/jimmunol.0804169","volume":"183","author":"A Andoh","year":"2009","unstructured":"Andoh, A. et al. Expression of IL-24, an activator of the JAK1\/STAT3\/SOCS3 cascade, is enhanced in inflammatory bowel disease. J. Immunol. 183, 687\u2013695 (2009).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR111","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s10875-012-9843-4","volume":"33","author":"G Fonseca-Camarillo","year":"2013","unstructured":"Fonseca-Camarillo, G., Furuzawa-Carballeda, J., Llorente, L. & Yamamoto-Furusho, J. K. IL-10- and IL-20-expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis. J. Clin. Immunol. 33, 640\u2013648 (2013).","journal-title":"J. Clin. Immunol."},{"key":"BFnrd4176_CR112","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.crohns.2012.06.015","volume":"7","author":"A Dige","year":"2013","unstructured":"Dige, A. et al. Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease. J. Crohns Colitis 7, 248\u2013255 (2013).","journal-title":"J. Crohns Colitis"},{"key":"BFnrd4176_CR113","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.immuni.2008.11.003","volume":"29","author":"LA Zenewicz","year":"2008","unstructured":"Zenewicz, L. A. et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947\u2013957 (2008).","journal-title":"Immunity"},{"key":"BFnrd4176_CR114","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.4049\/jimmunol.1300016","volume":"190","author":"LA Zenewicz","year":"2013","unstructured":"Zenewicz, L. A. et al. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J. Immunol. 190, 5306\u20135312 (2013).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR115","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1084\/jem.20082683","volume":"206","author":"G Pickert","year":"2009","unstructured":"Pickert, G. et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206, 1465\u20131472 (2009).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR116","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1084\/jem.20090900","volume":"206","author":"M Munoz","year":"2009","unstructured":"Munoz, M. et al. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 206, 3047\u20133059 (2009).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR117","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.20102149","volume":"208","author":"M Kamanaka","year":"2011","unstructured":"Kamanaka, M. et al. Memory\/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology. J. Exp. Med. 208, 1027\u20131040 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR118","doi-asserted-by":"publisher","first-page":"60ra88","DOI":"10.1126\/scitranslmed.3001500","volume":"2","author":"MJ Broadhurst","year":"2010","unstructured":"Broadhurst, M. J. et al. IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient. Sci Transl Med. 2, 60ra88 (2010).","journal-title":"Sci Transl Med."},{"key":"BFnrd4176_CR119","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1164\/rccm.201008-1383OC","volume":"183","author":"AG Besnard","year":"2011","unstructured":"Besnard, A. G. et al. Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. Am. J. Respir. Crit. Care Med. 183, 1153\u20131163 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrd4176_CR120","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1399-3038.2010.01116.x","volume":"22","author":"V Farfariello","year":"2011","unstructured":"Farfariello, V. et al. IL-22 mRNA in peripheral blood mononuclear cells from allergic rhinitic and asthmatic pediatric patients. Pediatr. Allergy Immunol. 22, 419\u2013423 (2011).","journal-title":"Pediatr. Allergy Immunol."},{"key":"BFnrd4176_CR121","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jaci.2011.06.018","volume":"128","author":"K Takahashi","year":"2011","unstructured":"Takahashi, K. et al. IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation. J. Allergy Clin. Immunol. 128, 1067\u20131076 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrd4176_CR122","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.4049\/jimmunol.1001560","volume":"187","author":"K Nakagome","year":"2011","unstructured":"Nakagome, K. et al. High expression of IL-22 suppresses antigen-induced immune responses and eosinophilic airway inflammation via an IL-10-associated mechanism. J. Immunol. 187, 5077\u20135089 (2011).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR123","doi-asserted-by":"publisher","first-page":"8816","DOI":"10.1074\/jbc.M111.304758","volume":"287","author":"C Paget","year":"2012","unstructured":"Paget, C. et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J. Biol. Chem. 287, 8816\u20138829 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnrd4176_CR124","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nm.2684","volume":"18","author":"M Kudo","year":"2012","unstructured":"Kudo, M. et al. IL-17A produced by \u03b1\u03b2 T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nature Med. 18, 547\u2013554 (2012).","journal-title":"Nature Med."},{"key":"BFnrd4176_CR125","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1084\/jem.20100061","volume":"207","author":"PL Simonian","year":"2010","unstructured":"Simonian, P. L. et al. \u03b3\u03b4 T cells protect against lung fibrosis via IL-22. J. Exp. Med. 207, 2239\u20132253 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR126","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1165\/rcmb.2009-0440OC","volume":"44","author":"S Hoegl","year":"2011","unstructured":"Hoegl, S. et al. Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury. Am. J. Respir. Cell. Mol. Biol. 44, 369\u2013376 (2011).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"BFnrd4176_CR127","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1084\/jem.20092054","volume":"207","author":"GF Sonnenberg","year":"2010","unstructured":"Sonnenberg, G. F. et al. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J. Exp. Med. 207, 1293\u20131305 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR128","doi-asserted-by":"publisher","first-page":"e17171","DOI":"10.1371\/journal.pone.0017171","volume":"6","author":"AC Graham","year":"2011","unstructured":"Graham, A. C. et al. IL-22 production is regulated by IL-23 during Listeria monocytogenes infection but is not required for bacterial clearance or tissue protection. PLoS ONE 6, e17171 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrd4176_CR129","doi-asserted-by":"publisher","first-page":"7891","DOI":"10.4049\/jimmunol.181.11.7891","volume":"181","author":"SM Schulz","year":"2008","unstructured":"Schulz, S. M. et al. Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. J. Immunol. 181, 7891\u20137901 (2008).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR130","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.immuni.2009.08.025","volume":"31","author":"Y Lin","year":"2009","unstructured":"Lin, Y. et al. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31, 799\u2013810 (2009).","journal-title":"Immunity"},{"key":"BFnrd4176_CR131","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1126\/science.1222551","volume":"336","author":"GF Sonnenberg","year":"2012","unstructured":"Sonnenberg, G. F. et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336, 1321\u20131325 (2012).","journal-title":"Science"},{"key":"BFnrd4176_CR132","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature10554","volume":"479","author":"K Berer","year":"2011","unstructured":"Berer, K. et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479, 538\u2013541 (2011).","journal-title":"Nature"},{"key":"BFnrd4176_CR133","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.1233521","volume":"339","author":"JG Markle","year":"2013","unstructured":"Markle, J. G. et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084\u20131088 (2013).","journal-title":"Science"},{"key":"BFnrd4176_CR134","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1128\/IAI.05939-11","volume":"80","author":"MA Gessner","year":"2012","unstructured":"Gessner, M. A. et al. Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus. Infect. Immun. 80, 410\u2013417 (2012).","journal-title":"Infect. Immun."},{"key":"BFnrd4176_CR135","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/mi.2010.22","volume":"3","author":"A De Luca","year":"2010","unstructured":"De Luca, A. et al. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 3, 361\u2013373 (2010).","journal-title":"Mucosal Immunol."},{"key":"BFnrd4176_CR136","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.4049\/jimmunol.1001153","volume":"185","author":"S Kagami","year":"2010","unstructured":"Kagami, S., Rizzo, H. L., Kurtz, S. E., Miller, L. S. & Blauvelt, A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J. Immunol. 185, 5453\u20135462 (2010).","journal-title":"J. Immunol."},{"key":"BFnrd4176_CR137","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1084\/jem.20091669","volume":"207","author":"K Kisand","year":"2010","unstructured":"Kisand, K. et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J. Exp. Med. 207, 299\u2013308 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR138","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.ajpath.2012.12.007","volume":"182","author":"DA Pociask","year":"2013","unstructured":"Pociask, D. A. et al. IL-22 is essential for lung epithelial repair following influenza infection. Am. J. Pathol. 182, 1286\u20131296 (2013).","journal-title":"Am. J. Pathol."},{"key":"BFnrd4176_CR139","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1128\/JVI.02943-12","volume":"87","author":"S Ivanov","year":"2013","unstructured":"Ivanov, S. et al. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection. J. Virol. 87, 6911\u20136924 (2013).","journal-title":"J. Virol."},{"key":"BFnrd4176_CR140","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/mi.2012.38","volume":"5","author":"NR Klatt","year":"2012","unstructured":"Klatt, N. R. et al. Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 5, 646\u2013657 (2012).","journal-title":"Mucosal Immunol."},{"key":"BFnrd4176_CR141","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/mi.2012.72","volume":"5","author":"CJ Kim","year":"2012","unstructured":"Kim, C. J. et al. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol. 5, 670\u2013680 (2012).","journal-title":"Mucosal Immunol."},{"key":"BFnrd4176_CR142","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cyto.2007.11.016","volume":"41","author":"J Dambacher","year":"2008","unstructured":"Dambacher, J. et al. The role of interleukin-22 in hepatitis C virus infection. Cytokine 41, 209\u2013216 (2008).","journal-title":"Cytokine"},{"key":"BFnrd4176_CR143","first-page":"43","volume":"1","author":"H Pan","year":"2004","unstructured":"Pan, H., Hong, F., Radaeva, S. & Gao, B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell. Mol. Immunol. 1, 43\u201349 (2004).","journal-title":"Cell. Mol. Immunol."},{"key":"BFnrd4176_CR144","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","volume":"27","author":"LA Zenewicz","year":"2007","unstructured":"Zenewicz, L. A. et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27, 647\u2013659 (2007).","journal-title":"Immunity"},{"key":"BFnrd4176_CR145","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1271\/bbb.110061","volume":"75","author":"WW Xing","year":"2011","unstructured":"Xing, W. W. et al. Interleukin-22 protects against acute alcohol-induced hepatotoxicity in mice. Biosci. Biotechnol. Biochem. 75, 1290\u20131294 (2011).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"BFnrd4176_CR146","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/TP.0b013e3182449136","volume":"93","author":"PJ Chestovich","year":"2012","unstructured":"Chestovich, P. J. et al. Interleukin-22: implications for liver ischemia-reperfusion injury. Transplantation 93, 485\u2013492 (2012).","journal-title":"Transplantation"},{"key":"BFnrd4176_CR147","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fimmu.2012.00085","volume":"3","author":"B Mastelic","year":"2012","unstructured":"Mastelic, B. et al. IL-22 protects against liver pathology and lethality of an experimental blood-stage malaria infection. Front. Immunol. 3, 85 (2012).","journal-title":"Front. Immunol."},{"key":"BFnrd4176_CR148","doi-asserted-by":"publisher","first-page":"G74","DOI":"10.1152\/ajpgi.00075.2009","volume":"298","author":"X Ren","year":"2010","unstructured":"Ren, X., Hu, B. & Colletti, L. M. IL-22 is involved in liver regeneration after hepatectomy. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G74\u2013G80 (2010).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrd4176_CR149","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/art.24568","volume":"60","author":"H Shen","year":"2009","unstructured":"Shen, H., Goodall, J. C. & Hill Gaston, J. S. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 60, 1647\u20131656 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrd4176_CR150","doi-asserted-by":"publisher","first-page":"R196","DOI":"10.1186\/ar3168","volume":"12","author":"R Cascao","year":"2010","unstructured":"Cascao, R. et al. Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res. Ther. 12, R196 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrd4176_CR151","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/ard.2011.152074","volume":"70","author":"J Leipe","year":"2011","unstructured":"Leipe, J. et al. Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis. Ann. Rheum. Dis. 70, 1453\u20131457 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrd4176_CR152","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s10875-011-9540-8","volume":"31","author":"L Zhang","year":"2011","unstructured":"Zhang, L. et al. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J. Clin. Immunol. 31, 606\u2013614 (2011).","journal-title":"J. Clin. Immunol."},{"key":"BFnrd4176_CR153","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3899\/jrheum.111027","volume":"39","author":"LF da Rocha Jr","year":"2012","unstructured":"da Rocha, L. F. Jr et al. Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity. J. Rheumatol 39, 1320\u20131325 (2012).","journal-title":"J. Rheumatol"},{"key":"BFnrd4176_CR154","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/art.24220","volume":"60","author":"L Geboes","year":"2009","unstructured":"Geboes, L. et al. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL\/6 mice. Arthritis Rheum. 60, 390\u2013395 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrd4176_CR155","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1002\/art.30469","volume":"63","author":"RJ Marijnissen","year":"2011","unstructured":"Marijnissen, R. J. et al. Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation. Arthritis Rheum. 63, 2939\u20132948 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrd4176_CR156","doi-asserted-by":"crossref","unstructured":"van Hamburg, J. P. et al. IL-17\/Th17 mediated synovial inflammation is IL-22 independent. Ann. Rheum. Dis. (2013).","DOI":"10.1136\/annrheumdis-2012-202373"},{"key":"BFnrd4176_CR157","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/art.37849","volume":"65","author":"S Sarkar","year":"2013","unstructured":"Sarkar, S., Zhou, X., Justa, S. & Bommireddy, S. R. Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10. Arthritis Rheum. 65, 960\u2013971 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrd4176_CR158","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cyto.2007.10.004","volume":"41","author":"TW Kragstrup","year":"2008","unstructured":"Kragstrup, T. W. et al. The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine 41, 16\u201323 (2008).","journal-title":"Cytokine"},{"key":"BFnrd4176_CR159","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1002\/art.27689","volume":"62","author":"YH Hsu","year":"2010","unstructured":"Hsu, Y. H. & Chang, M. S. Interleukin-20 antibody is a potential therapeutic agent for experimental arthritis. Arthritis Rheum. 62, 3311\u20133321 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrd4176_CR160","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1084\/jem.20102234","volume":"208","author":"YH Hsu","year":"2011","unstructured":"Hsu, Y. H. et al. Anti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss. J. Exp. Med. 208, 1849\u20131861 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR161","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock, J. P. et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4\u2212CD8\u2212 entheseal resident T cells. Nature Med. 18, 1069\u20131076 (2012). This is the first description of an important role of IL-22 in enthesis.","journal-title":"Nature Med."},{"key":"BFnrd4176_CR162","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2407-13-59","volume":"13","author":"R Jiang","year":"2013","unstructured":"Jiang, R. et al. IL-22 is related to development of human colon cancer by activation of STAT3. BMC Cancer 13, 59 (2013).","journal-title":"BMC Cancer"},{"key":"BFnrd4176_CR163","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s00262-012-1241-5","volume":"61","author":"Y Zhuang","year":"2012","unstructured":"Zhuang, Y. et al. Increased intratumoral IL-22-producing CD4+ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival. Cancer Immunol. Immunother. 61, 1965\u20131975 (2012).","journal-title":"Cancer Immunol. Immunother."},{"key":"BFnrd4176_CR164","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/hep.24486","volume":"54","author":"R Jiang","year":"2011","unstructured":"Jiang, R. et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 54, 900\u2013909 (2011).","journal-title":"Hepatology"},{"key":"BFnrd4176_CR165","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/JTO.0b013e31829923c8","volume":"8","author":"S Kobold","year":"2013","unstructured":"Kobold, S. et al. Interleukin-22 Is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells. J. Thorac. Oncol. 8, 1032\u20131042 (2013).","journal-title":"J. Thorac. Oncol."},{"key":"BFnrd4176_CR166","doi-asserted-by":"publisher","first-page":"e23737","DOI":"10.1371\/journal.pone.0023737","volume":"6","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. High fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overexpression of interleukin 22. PLoS ONE 6, e23737 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrd4176_CR167","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1084\/jem.20122308","volume":"210","author":"S Kirchberger","year":"2013","unstructured":"Kirchberger, S. et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J. Exp. Med. 210, 917\u2013931 (2013).","journal-title":"J. Exp. Med."},{"key":"BFnrd4176_CR168","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrd3930","volume":"12","author":"M Croft","year":"2013","unstructured":"Croft, M., Benedict, C. A. & Ware, C. F. Clinical targeting of the TNF and TNFR superfamilies. Nature Rev. Drug Discov. 12, 147\u2013168 (2013).","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrd4176_CR169","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","volume":"371","author":"KA Papp","year":"2008","unstructured":"Papp, K. A. et al. Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371, 1675\u20131684 (2008).","journal-title":"Lancet"},{"key":"BFnrd4176_CR170","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","volume":"371","author":"CL Leonardi","year":"2008","unstructured":"Leonardi, C. L. et al. Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371, 1665\u20131674 (2008).","journal-title":"Lancet"},{"key":"BFnrd4176_CR171","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","volume":"366","author":"C Leonardi","year":"2012","unstructured":"Leonardi, C. et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N. Engl. J. Med. 366, 1190\u20131199 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrd4176_CR172","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","volume":"11","author":"P Miossec","year":"2012","unstructured":"Miossec, P. & Kolls, J. K. Targeting IL-17 and TH17 cells in chronic inflammation. Nature Rev. Drug Discov. 11, 763\u2013776 (2012). This review highlights the biology of IL-17 and T H 17 cells, their role in disease and clinical trials using IL-17 and IL-17R inhibitors.","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnrd4176_CR173","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.it.2012.02.007","volume":"33","author":"R F\u00f6rster","year":"2012","unstructured":"F\u00f6rster, R., Braun, A. & Worbs T. Lymph node homing of T cells and dendritic cells via afferent lymphatics. Trends Immunol. 33, 271\u2013280 (2012).","journal-title":"Trends Immunol."}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrd4176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd4176","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd4176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:21:53Z","timestamp":1684452113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrd4176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,31]]},"references-count":173,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFnrd4176"],"URL":"https:\/\/doi.org\/10.1038\/nrd4176","relation":{},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,31]]}}}